New Once-Monthly Obesity Peptides Enter FDA Review
The peptide revolution in obesity treatment is advancing rapidly, with pharmaceutical company Ascletis submitting two Investigational New Drug (IND) applications to the U.S. FDA for novel once-monthly obesity peptides. This development represents a significant evolution in the weight management landscape that has captured attention across the bodybuilding, biohacking, and longevity communities—areas where Tony Huge has […]
Biohacker Diagnosed With Incurable Illness: A Warning
The biohacking community faces a sobering reality check as reports emerge of a well-known biohacker being diagnosed with an incurable illness described as the body “eating itself.” According to The Nightly, this development has sent shockwaves through the self-optimization movement, raising critical questions about the risks and rewards of aggressive biohacking protocols. This news comes […]
New Obesity Peptides: Amylin & GLP-1 Receptor Agonists
The landscape of pharmaceutical peptides for weight management is rapidly evolving, with new developments that could significantly impact the bodybuilding, biohacking, and body composition optimization communities. According to a recent announcement from Yahoo Finance UK, Ascletis Pharma has submitted two Investigational New Drug (IND) applications to the U.S. FDA for novel obesity treatments: ASC36, a […]
Biohacker’s Incurable Illness: A Cautionary Tale
The biohacking community has been shaken by recent revelations from a prominent figure who disclosed suffering from an incurable stomach condition. As reported by The Australian, the biohacker’s candid admission—”my stomach is eating itself”—has sparked important conversations about the risks and rewards of extreme health optimization protocols, a topic highly relevant to followers of Tony […]
Bryan Johnson’s Stomach Illness: Biohacking Risks Exposed
The biohacking community has been shaken by recent news that prominent biohacker Bryan Johnson has revealed an incurable stomach illness, describing the condition as his “stomach eating itself.” The disclosure, reported by Nine.com.au, raises critical questions about the potential risks associated with extreme health optimization protocols—a topic that resonates deeply within the bodybuilding, peptides, and […]
New Monthly Peptide Obesity Treatment Enters FDA Review
The peptide revolution in metabolic health continues to accelerate as pharmaceutical company Ascletis recently submitted two Investigational New Drug (IND) applications to the U.S. FDA for novel obesity treatments. These submissions represent a significant advancement in peptide-based therapeutics that could reshape how the bodybuilding, biohacking, and longevity communities approach body composition optimization and metabolic health. […]
New Drug Targets Ozempic Muscle Loss: What Tony Huge Says
The rapid rise of GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro has transformed the weight loss landscape, but a concerning side effect has emerged: significant muscle loss alongside fat reduction. According to a recent report from Yahoo Health, a new pharmaceutical intervention may offer a solution to the dreaded “Ozempic butt” and other muscle-wasting […]
New Monthly Peptide Injections Target Obesity Treatment
The peptide therapeutics landscape continues to evolve at a rapid pace, with pharmaceutical companies now developing once-monthly injectable formulations that could revolutionize obesity treatment. According to The Manila Times, Ascletis Pharma has submitted two Investigational New Drug (IND) applications to the U.S. FDA for novel peptide-based obesity treatments: ASC36, a once-monthly amylin receptor agonist, and […]
Jordan Hutchinson Wins 2026 Portugal Pro Men’s Open
The competitive bodybuilding world witnessed another milestone as Jordan Hutchinson claimed victory at the 2026 Mr. Big Evolution Portugal Pro in the Men’s Open division. According to Fitness Volt, this victory marks a significant achievement in the professional bodybuilding circuit and raises important questions about the cutting-edge optimization strategies that separate champions from competitors in […]
RAD140 Study: New Research on Muscle Growth & Bone Density
A new preclinical study published by Wiley & Sons has reignited scientific interest in RAD140 (Testolone), one of the most widely discussed selective androgen receptor modulators (SARMs) in the bodybuilding and biohacking communities. The research specifically examines RAD140’s potential to increase muscle mass and bone mineral density, parameters that have made this compound a subject […]